Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongnan Mo

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Frontiers of Medicine|August 14, 2020
Progress in systemic therapy for triple-negative breast cancerHongnan Mo, Binghe Xu
International Journal of Molecular Sciences|March 14, 2026
Applications of Metabolomics to the Clinical Management of Breast Cancer: New Perspectives for Diagnosis, Treatment and PrognosisYuqiu Li, Hongnan Mo
Journal of Cancer Research and Clinical Oncology|June 1, 2020
Appropriate arrangement of cancer treatment after COVID-19 epidemic peaks in ChinaHongnan Mo, Binliang Liu, Fei Ma
Cancer Innovation|July 31, 2024
Chinese expert consensus on an innovative patient-centered approach to diagnosis and treatment of cancerHongnan Mo, Ruiqi Zhong, Fei Ma
Cancer Innovation|November 12, 2025
Metronomic Chemotherapy in Breast Cancer: Unleashing the Potential of Combination RegimensJiaxuan Liu, Hongnan Mo, Qiao Li, et al.
Thoracic Cancer|March 14, 2024
Impact of HER2-low expression on the efficacy of endocrine therapy with or without CDK4/6 inhibitor in HR-positive/HER2-negative metastatic breast cancer: A prospective studyYun Wu, Hongnan Mo, Hangcheng Xu, et al.
Clinical and Translational Medicine|February 25, 2025
Predictive circulating biomarkers of the response to anti-PD-1 immunotherapy in advanced HER2 negative breast cancerYuhan Wei, Hewei Ge, Yalong Qi, et al.
Nature Communications|December 11, 2025
Biologically-informed integration of drug representations for breast cancer treatment using deep learningHewei Ge, Hongnan Mo, Yuhan Wei, et al.
BMC Cancer|December 15, 2021
Clinicopathological characteristics and survival outcomes in patients with synchronous lung metastases upon initial metastatic breast cancer diagnosis in Han populationShaoyan Lin, Hongnan Mo, Yiqun Li, et al.
Thoracic Cancer|April 19, 2022
Prognostic and predictive impact of neutrophil-to-lymphocyte ratio and HLA-I genotyping in advanced esophageal squamous cell carcinoma patients receiving immune checkpoint inhibitor monotherapyLin Wang, Yanrong Zhu, Bo Zhang, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Frontiers of Medicine|August 14, 2020
Progress in systemic therapy for triple-negative breast cancerHongnan Mo, Binghe Xu
International Journal of Molecular Sciences|March 14, 2026
Applications of Metabolomics to the Clinical Management of Breast Cancer: New Perspectives for Diagnosis, Treatment and PrognosisYuqiu Li, Hongnan Mo
Journal of Cancer Research and Clinical Oncology|June 1, 2020
Appropriate arrangement of cancer treatment after COVID-19 epidemic peaks in ChinaHongnan Mo, Binliang Liu, Fei Ma
Cancer Innovation|July 31, 2024
Chinese expert consensus on an innovative patient-centered approach to diagnosis and treatment of cancerHongnan Mo, Ruiqi Zhong, Fei Ma
Cancer Innovation|November 12, 2025
Metronomic Chemotherapy in Breast Cancer: Unleashing the Potential of Combination RegimensJiaxuan Liu, Hongnan Mo, Qiao Li, et al.
Thoracic Cancer|March 14, 2024
Impact of HER2-low expression on the efficacy of endocrine therapy with or without CDK4/6 inhibitor in HR-positive/HER2-negative metastatic breast cancer: A prospective studyYun Wu, Hongnan Mo, Hangcheng Xu, et al.
Clinical and Translational Medicine|February 25, 2025
Predictive circulating biomarkers of the response to anti-PD-1 immunotherapy in advanced HER2 negative breast cancerYuhan Wei, Hewei Ge, Yalong Qi, et al.
Nature Communications|December 11, 2025
Biologically-informed integration of drug representations for breast cancer treatment using deep learningHewei Ge, Hongnan Mo, Yuhan Wei, et al.
BMC Cancer|December 15, 2021
Clinicopathological characteristics and survival outcomes in patients with synchronous lung metastases upon initial metastatic breast cancer diagnosis in Han populationShaoyan Lin, Hongnan Mo, Yiqun Li, et al.
Thoracic Cancer|April 19, 2022
Prognostic and predictive impact of neutrophil-to-lymphocyte ratio and HLA-I genotyping in advanced esophageal squamous cell carcinoma patients receiving immune checkpoint inhibitor monotherapyLin Wang, Yanrong Zhu, Bo Zhang, et al.
Pageof 6